Oracle Investment Management Inc.
13
21M
11
0.46
3
0.15
6
- Stages of investment
- Areas of investment
Summary
In 1993 was created Oracle Investment Management Inc., which is appeared as VC. The venture was found in North America in United States. The leading representative office of defined VC is situated in the Greenwich.
The overall number of key employees were 1.
The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Oracle Investment Management Inc., startups are often financed by US Department of Energy, U.S. Department of Agriculture, Matthew W. Strobeck. The meaningful sponsors for the fund in investment in the same round are Jack Schuler, Westwood Holdings Group, Venrock. In the next rounds fund is usually obtained by Oracle, M12, Jack Schuler.
The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 deals per year. This Oracle Investment Management Inc. works on 31 percentage points more the average amount of lead investments comparing to the other organizations. Considering the real fund results, this VC is 0 percentage points less often commits exit comparing to other organizations. The increased amount of exits for fund were in 2003. The top activity for fund was in 2014. Despite it in 2019 the fund had an activity.
Moreover, a startup needs to be at the age of 16-20 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Biolase, Concentric Analgesics, Vermillion. We can highlight the next thriving fund investment areas, such as Developer Tools, Chemical. The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 3 or 5+ of the founder, the probability for it to get the investment is little. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
Investments analytics
Analytics
- Total investments
- 13
- Lead investments
- 3
- Exits
- 6
- Rounds per year
- 0.46
- Follow on index
- 0.15
- Investments by industry
- Biotechnology (9)
- Health Care (5)
- Health Diagnostics (3)
- Medical Device (3)
- Medical (3) Show 23 more
- Investments by region
-
- United States (9)
- Canada (2)
- United Kingdom (1)
- Israel (1)
- Peak activity year
- 2014
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 17
- Avg. valuation at time of investment
- 24M
- Group Appearance index
- 0.62
- Avg. company exit year
- 17
- Avg. multiplicator
- 0.95
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Pyramid Biosciences | 15 Oct 2021 | Biotechnology, Life Science | Early Stage Venture | 33M | United States, Massachusetts |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.